Chemoinformaics analysis of indole-3-alkylmamines – hypaphorine
| Molecular Weight | 246.31 | nRot | 4 |
| Heavy Atom Molecular Weight | 228.166 | nRig | 11 |
| Exact Molecular Weight | 246.137 | nRing | 2 |
| Solubility: LogS | 0.322 | nHRing | 1 |
| Solubility: LogP | -2.079 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 10 |
| nHA | 2 | APOL | 39.1863 |
| nHD | 1 | BPOL | 22.6437 |
| QED | 0.8 |
| Synth | 3.382 |
| Natural Product Likeliness | 0.31 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.113 |
| HIA | 0.739 |
| CACO-2 | -5.505 |
| MDCK | 0.0000138 |
| BBB | 0.317 |
| PPB | 0.119969 |
| VDSS | 0.817 |
| FU | 0.847367 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.879 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.815 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.794 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.057 |
| CL | 3.09 |
| T12 | 0.943 |
| hERG | 0.004 |
| Ames | 0.003 |
| ROA | 0.444 |
| SkinSen | 0.028 |
| Carcinogencity | 0.066 |
| EI | 0.141 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.621798 |